67 related articles for article (PubMed ID: 21093207)
1. Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: potential markers for aggressive phenotypes.
Salajegheh A; Smith RA; Kasem K; Gopalan V; Nassiri MR; William R; Lam AK
Eur J Surg Oncol; 2011 Jan; 37(1):93-9. PubMed ID: 21093207
[TBL] [Abstract][Full Text] [Related]
2. The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma.
Yu XM; Lo CY; Lam AK; Lang BH; Leung P; Luk JM
Surgery; 2008 Dec; 144(6):934-40; discussion 940-1. PubMed ID: 19041000
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of the expression of TGF-alpha and EGFR in papillary thyroid carcinoma: clinicopathological relevance.
Lam AK; Lau KK; Gopalan V; Luk J; Lo CY
Pathology; 2011 Jan; 43(1):40-7. PubMed ID: 21240064
[TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factor family messenger RNA in diseased thyroid tissues.
Tanaka K; Kurebayashi J; Sonoo H; Otsuki T; Yamamoto Y; Ohkubo S; Yamamoto S; Shimozuma K
Surg Today; 2002; 32(9):761-8. PubMed ID: 12203051
[TBL] [Abstract][Full Text] [Related]
5. Expression of estrogen receptor, progesterone receptor, and vascular endothelial growth factor-A in thyroid cancer.
Kansakar E; Chang YJ; Mehrabi M; Mittal V
Am Surg; 2009 Sep; 75(9):785-9; discussion 789. PubMed ID: 19774949
[TBL] [Abstract][Full Text] [Related]
6. Interrelated overexpression of endothelial and inducible nitric oxide synthases, endothelin-1 and angiogenic factors in human papillary thyroid carcinoma.
Donckier JE; Michel L; Delos M; Havaux X; Van Beneden R
Clin Endocrinol (Oxf); 2006 Jun; 64(6):703-10. PubMed ID: 16712675
[TBL] [Abstract][Full Text] [Related]
7. [Expression and significance of VEGF, VEGF-C, and VEGF-D in papillary thyroid carcinoma].
Jiang HG; Gao M; Tang WP; Li FH; Cai QZ
Ai Zheng; 2005 Sep; 24(9):1136-9. PubMed ID: 16159441
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
[TBL] [Abstract][Full Text] [Related]
9. [Expression of VEGF-C and angiogenesis, and lymphangiogenesis in papillary thyroid carcinoma].
Liang QC; Wei QY; Fan SQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):414-6, 419. PubMed ID: 16859137
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
[TBL] [Abstract][Full Text] [Related]
11. [Association of genetic polymorphisms and haplotypes in hMLH1 and hMSH3 gene with the risk of papillary thyroid carcinoma].
Shi WP; Bian JC; Jiang F; Ni HX; Zhu QX; Tang HW; Shen Q; Wu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):390-5. PubMed ID: 18683134
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour.
de la Torre NG; Buley I; Wass JA; Turner HE
Endocr Relat Cancer; 2006 Sep; 13(3):931-44. PubMed ID: 16954441
[TBL] [Abstract][Full Text] [Related]
13. [Somatic mutations of mitochondrial DNA in thyroid papillary carcinoma].
Sun TQ; Wu Y; Ji QH; Bian JC; Wang ZY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Oct; 41(10):782-5. PubMed ID: 17190430
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of vascular endothelial growth factor for thyroid neoplasms.
Huang SM; Lee JC; Wu TJ; Chow NH
World J Surg; 2001 Mar; 25(3):302-6. PubMed ID: 11343180
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor gene polymorphisms in thyroid cancer.
Hsiao PJ; Lu MY; Chiang FY; Shin SJ; Tai YD; Juo SH
J Endocrinol; 2007 Nov; 195(2):265-70. PubMed ID: 17951537
[TBL] [Abstract][Full Text] [Related]
16. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
Yu XM; Lo CY; Lam AK; Leung P; Luk JM
Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer.
Kim JG; Chae YS; Sohn SK; Cho YY; Moon JH; Park JY; Jeon SW; Lee IT; Choi GS; Jun SH
Clin Cancer Res; 2008 Jan; 14(1):62-6. PubMed ID: 18172253
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of different proteins expression between papillary thyroid carcinoma and normal thyroid tissue].
Bian X; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Apr; 45(4):318-23. PubMed ID: 20627053
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor (VEGF) in human thyroid tumors.
Lewy-Trenda I; Wierzchniewska-Ławska A
Pol J Pathol; 2002; 53(3):129-32. PubMed ID: 12476614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
